Remove tag sustainability
article thumbnail

Electronic smart packaging market to value nearly $3b in 2033

European Pharmaceutical Review

Yet apart from radio-frequency identification (RFID) tags and QR codes, adoption at scale has proved challenging overall, the report stated. Types of technologies such as wirelessly connected tags (active and passive) and sensors were also specified. This is driving the adoption of item-level smart labelling , the report noted.

article thumbnail

Free access to Zolgensma curbed, says Novartis

pharmaphorum

. “With these advancements in mind, we are redefining the geographic scope of the [gMAP] to countries where it is currently possible to make Zolgensma available as a future long-term sustainable solution,” said Novartis in a statement on the changes, adding they will “ultimately benefit more patients over time.”

118
118
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Second unanimous FDA adcomm vote boosts bluebird bio

pharmaphorum

Beti-cel has already been approved for marketing in Europe as Zynteglo, with a price tag of around $1.8 million price tag, saying its ability to help patients reach sustained transfusion independence justified its high price. Beti-cel offers another potentially curative treatment for a much broader range of patients.

FDA 58
article thumbnail

The “Graziella Molinari Women in Pharma Award” Announced for 2022 Edition at the ISPE Italy Affiliate

ISPE

Winner of the ISPE Italy Affiliate’s Women in Pharma® Graziella Molinari Award in 2021, thanks to her project for the inclusion of #smart tags in a site production in order to improve not only efficiency, but also quality and compliance in a 4.0 Micaela Prati. perspective. .

98
article thumbnail

ICER says bluebird bio’s $2.1m gene therapy is cost-effective

pharmaphorum

million price tag. million if paid through an outcomes-based contract for patients with sustained transfusion independence.” US cost-effectiveness watchdog ICER has handed bluebird bio some good news ahead of its FDA advisory committee meeting for rare blood disorder gene therapy beti-cel in June, by endorsing its proposed $2.1

FDA 63
article thumbnail

How automation can help to address supply chain challenges in pharma

pharmaphorum

However, with a 74% increase in pharmaceutical supply chain disruption in 2021 , this approach cannot be sustained for much longer, not only due to the recent pandemic, but to growing geopolitical fragility exacerbating trade disputes and trade routes.

article thumbnail

Mounjaro (tirzepatide) alternatives: What can I take instead of Mounjaro?

The Checkup by Singlecare

Other GLP-1 receptor agonists (with indication for diabetes) If the price of Mounjaro or insurance coverage is not sustainable, the first move might be to find a GLP-1 drug with a lower price tag or better coverage on an insurance plan.